Clinical Trial Update: The Effect of Liraglutide on the Treatment of Coronary Artery Disease and Type 2 Diabetes [Phase 4]

View source ↗

Summary

This clinical trial update notes that the Phase 4 study evaluating liraglutide for coronary artery disease in patients with type 2 diabetes mellitus has complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• Victoza (Liraglutide)

Snippet

Sponsor: Haugaard, Steen Bendix, M.D., DMSc | Conditions: Coronary Artery Disease, Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED